Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Clin Genet ; 101(2): 233-241, 2022 02.
Artigo em Inglês | MEDLINE | ID: mdl-34842280

RESUMO

IMMT gene codes for mitofilin, a mitochondrial inner membrane protein that regulates the morphology of mitochondrial cristae. The phenotype associated with mutations in this gene has not been yet established, but functional studies carried out show that its loss causes a mitochondrial alteration, both in the morphology of the mitochondrial crests and in their function. We present two cousins from an extended highly consanguineous family with developmental encephalopathy, hypotonia, nystagmus due to optic neuropathy. The likely pathogenic homozygous c.895A>G (p.Lys299Glu) variant in the IMMT gene co-segregates with the disease and associates altered mitochondrial cristae observed by electron microscopy.


Assuntos
Homozigoto , Encefalomiopatias Mitocondriais/diagnóstico , Encefalomiopatias Mitocondriais/genética , Proteínas Mitocondriais , Proteínas Musculares , Mutação , Doenças do Nervo Óptico/diagnóstico , Doenças do Nervo Óptico/genética , Alelos , Substituição de Aminoácidos , Biópsia , Consanguinidade , Diagnóstico por Imagem , Predisposição Genética para Doença , Humanos , Lactente , Fenótipo , Avaliação de Sintomas
2.
Ocul Immunol Inflamm ; 32(9): 2159-2169, 2024 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-38728578

RESUMO

OBJECTIVE: To characterize and describe clinical experience with childhood-onset non-infectious uveitis. STUDY DESIGN: A multicenter retrospective multidisciplinary national web-based registry of 507 patients from 21 hospitals was analyzed. Cases were grouped as immune disease-associated (IMDu), idiopathic (IDIu) or ophthalmologically distinct. Characteristics of juvenile idiopathic arthritis-associated (non-HLA-B27-related) uveitis (JIAu), IDIu, and pars planitis (PP) were compared. RESULTS: IMDu (62.3%) and JIAu (51.9%) predominated in young females; and IDIu (22.7%) and PP (13.6%) in older children, without sex imbalance. Ocular complications occurred in 45.3% of cases (posterior synechiae [28%], cataracts [16%], band keratopathy [14%], ocular hypertension [11%] and cystoid macular edema [10%]) and were associated with synthetic (86%) and biologic (65%) disease-modifying antirheumatic drug (DMARD) use. Subgroups were significantly associated (p < 0.05) with different characteristics. JIAu was typically anterior (98%), insidious (75%), in ANA-positive (69%), young females (82%) with fewer complications (31%), better visual outcomes, and later use of uveitis-effective biologics. In contrast, IDIu was characteristically anterior (87%) or panuveitic (12.1%), with acute onset (60%) and more complications at onset (59%: synechiae [31%] and cataracts [9.6%]) and less DMARD use, while PP is intermediate, and was mostly bilateral (72.5%), persistent (86.5%) and chronic (86.8%), with more complications (70%; mainly posterior segment and cataracts at last visit), impaired visual acuity at onset, and greater systemic (81.2%), subtenon (29.1%) and intravitreal (10.1%) steroid use. CONCLUSION: Prognosis of childhood uveitis has improved in the "biologic era," particularly in JIAu. Early referral and DMARD therapy may reduce steroid use and improve outcomes, especially in PP and IDIu.


Assuntos
Uveíte , Humanos , Feminino , Masculino , Estudos Retrospectivos , Criança , Uveíte/tratamento farmacológico , Uveíte/diagnóstico , Adolescente , Espanha/epidemiologia , Pré-Escolar , Idade de Início , Acuidade Visual/fisiologia , Sistema de Registros , Antirreumáticos/uso terapêutico , Artrite Juvenil/tratamento farmacológico , Artrite Juvenil/complicações , Produtos Biológicos/uso terapêutico , Lactente
3.
Rom J Ophthalmol ; 67(3): 305-308, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37876503

RESUMO

Objective: Description of melphalan's toxicity in retinoblastoma treatment. Methods: Clinical case report. Results: We presented a case of unilateral retinoblastoma with vitreous seeding at diagnosis, in which the use of intravitreal melphalan produced many adverse reactions. Conclusions: Vitreous seedings have been one of the most important challenges in retinoblastoma treatment. Intravitreal melphalan has achieved the regression of vitreous seedings in a large percentage of cases. It is a safe treatment; however, it can produce toxicity, even with the standard dose of 20-30 µg, which has been poorly documented. Exhaustive follow-up of patients is recommended for an early diagnosis of possible adverse effects. Abbreviations: OS = left eye, RI = magnetic resonance imaging, OCT = optical coherence tomography.


Assuntos
Neoplasias da Retina , Retinoblastoma , Humanos , Retinoblastoma/diagnóstico , Retinoblastoma/tratamento farmacológico , Melfalan/efeitos adversos , Neoplasias da Retina/diagnóstico , Neoplasias da Retina/tratamento farmacológico , Antineoplásicos Alquilantes/efeitos adversos , Estudos Retrospectivos , Corpo Vítreo , Injeções Intravítreas , Inoculação de Neoplasia
4.
Rom J Ophthalmol ; 65(3): 293-295, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-35036656

RESUMO

Corneal dellen appeared as a complication after perilimbal conjunctival papilloma dissection in a six-year-old patient. Our purpose was to describe the use of plasma rich in growth factors (PRGF) fibrin membrane in covering the corneal defect after conventional medical treatment failure. PRGF fibrin membrane is an interesting therapeutical option to consider not only in adult patients, but also in children.


Assuntos
Fibrina , Peptídeos e Proteínas de Sinalização Intercelular , Adulto , Criança , Túnica Conjuntiva , Humanos , Plasma
5.
Rom J Ophthalmol ; 63(2): 184-187, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31334399

RESUMO

A 9-year-old girl from Equatorial Guinea presented to the emergency department complaining of foreign body sensation in her right eye. A thin and large, translucent, slowly moving, coiled worm was observed underneath the conjunctiva. Anterior segment optical coherence tomography revealed hyperreflective small areas surrounded by larger hyporeflective areas into the subconjunctival space. Loa loa microfilaria was evidenced on blood test. Surgical extraction of the subconjunctival worm was intended on slit lamp and under sedation in the operating room, but it was unsuccessful due to poor cooperation and rapid migration of the larva into the sub-Tenon's space. The patient received two cycles of oral albendazole and one cycle of diethylcarbamazine before achieving complete microfilaria seroconversion. Abbreviations: AS-OCT = Anterior Segment Optical Coherence Tomography, PCR = Polymerase Chain Reaction, DEC = diethylcarbamazine.


Assuntos
Segmento Anterior do Olho/diagnóstico por imagem , Túnica Conjuntiva/parasitologia , Doenças da Túnica Conjuntiva/diagnóstico , Infecções Oculares Parasitárias/diagnóstico , Loa , Loíase/diagnóstico , Tomografia de Coerência Óptica/métodos , Animais , Segmento Anterior do Olho/parasitologia , Criança , Túnica Conjuntiva/patologia , Doenças da Túnica Conjuntiva/parasitologia , Diagnóstico Diferencial , Infecções Oculares Parasitárias/parasitologia , Feminino , Humanos , Loíase/parasitologia
6.
J Pediatr Ophthalmol Strabismus ; 55(2): 85-92, 2018 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-29257187

RESUMO

Achromatopsia is a complex inherited retinal disease that affects the cone cell function. It is usually an autosomal-recessive disease and is characterized by pendular nystagmus, poor visual acuity, lack of color vision, and marked photophobia. CNGA3, CNGB3, GNAT2, PDE6C, PDE6H, and ATF6 gene mutations have been identified as associated with this disease. New diagnostic and therapeutic tools are being studied. Optical coherence tomography and fundus autofluorescence are important imaging techniques that provide significant information about the progression of the disease. The genetic approach for these patients is a current important issue and gene therapy is an ongoing therapeutic option already being studied in clinical trials. The purpose of this review was to survey the current knowledge on diagnosis and treatment options in achromatopsia. [J Pediatr Ophthalmol Strabismus. 2018;55(2):85-92.].


Assuntos
Defeitos da Visão Cromática , Visão de Cores/fisiologia , Gerenciamento Clínico , Eletrorretinografia/métodos , Angiofluoresceinografia/métodos , Células Fotorreceptoras Retinianas Cones/patologia , Tomografia de Coerência Óptica/métodos , Defeitos da Visão Cromática/diagnóstico , Defeitos da Visão Cromática/fisiopatologia , Defeitos da Visão Cromática/terapia , Fundo de Olho , Humanos , Fenótipo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA